- Sonnenschein C, Soto AM (1999) The society
of cells: cancer and control of cell proliferation.
Springer, New York - Soto AM, Sonnenschein C (2004) The somatic
mutation theory of cancer: growing problems
with the paradigm? BioEssays 26
(10):1097–1107 - Jaffe L (2005) Response to paper by Henry
Harris. BioEssays 27(11):1206 - Feinberg AP, Ohlsson R, Henikoff S (2006)
The epigenetic progenitor origin of human
cancer. Nat Rev Genet 7(1):21–33 - Heng HHQ et al (2006) Cancer progression
by non-clonal chromosome aberrations. J Cell
Biochem 98(6):1424–1435 - Harris DP et al (2005) Regulation of
IFN-gamma production by B effector 1 cells:
essential roles for T-bet and the IFN-gamma
receptor. J Immunol 174(11):6781–6790 - Huang A et al (2002) Serum tryptophan
decrease correlates with immune activation
and impaired quality of life in colorectal cancer.
Br J Cancer 86(11):1691–1696 - Martien S, Abbadie C (2007) Acquisition of
oxidative DNA damage during senescence:
the first step toward carcinogenesis? Ann N Y
Acad Sci 1119:51–63 - Mintz B, Illmensee K (1975) Normal geneti-
cally mosaic mice produced from malignant
tera-tocarcinoma cells. Proc Natl Acad Sci U S
A 72:3585–3589 - Hochedlinger K, Blelloch R, Brennan C,
Yamada Y, Kim M, Chin L, Jaenisch R (2004)
Reprogramming of a melanoma genome by
nuclear transplantation. Genes Dev
18:1875–1885 - Kenny PA, Bissell MJ (2003) Tumor reversion:
correction of malignant behaviour by microen-
vironmental cues. Int J Cancer 107:688–695 - Lotem J, Sachs L (2002) Epigenetics wins over
genetics: induction of differentiation in tumor
cells. Semin Cancer Biol 12:339–346 - Sharpless NE, De Pinho RA (2007) How stem
cells age and why this makes us grow old. Nat
Rev Mol Cell Biol 8:703–713
39. Oakley EJ, Van Zant G (2007) Unraveling the
complex regulation of stem cells: implications
for aging and cancer. Leukemia 21:612–621
40. Finkel T, Serrano M, Blasco MA (2007) The
common biology of cancer and ageing. Nature
448:767–774
41. Soto AM, Maffini MV, Sonnenschein C (2008)
Neoplasia as development gone awry: the role
of endocrine disruptors. Int J Androl 31
(2):288–293
42. Biava, P. M. (1999). Complexity and cancer.
Leadership Medica 1. Vedi (accesso di marzo
2008)
43. Biava PM (2002) Complessita`e biologia. Il
cancro come patologia della comunicazione.
Mondadori, Milano
44. Abbs S, Bussoli T, Kavalier F (2004) Nature
encyclopaedia of the human genome. BJM
328:172
45. Marker PC (2008) Does prostate cancer co-opt
the developmental program? Differentiation
76:736–744
46. Soto AM, Sonnenschein C (2011) The tissue
organization field theory of cancer: a testable
replacement for the somatic mutation theory.
BioEssays 33(5):332–340
47. Rubin H (2011) Fields and field cancerization:
the preneoplastic origins of cancer: asymptom-
atic hyperplastic fields are precursors of neopla-
sia, and their progression to tumors can be
tracked by saturation density in culture. BioEs-
says 33(3):224–231
48. Capp J-P (2005) Stochastic gene expression,
disruption of tissue averaging effects and can-
cer as a disease of development. BioEssays 27
(12):1277–1285
49. Maitra A et al (2005) Genomic alterations in
cultured human embryonic stem cells. Nat
Genet 37(10):1099–1103
50. Prehn RT (1994) Cancers beget mutations ver-
sus mutations beget cancers. Cancer Res 54
(20):5296–5300
Conceptual Challenges in Systems Biology 13